Article

OVD dual pack gets FDA approval

Abbott has received FDA approval for its Healon Duet Dual Pack OVD, which includes Healon and Healon EndoCoat OVDs in separate sterile trays.

 

Abbott Park, IL-Abbott has received FDA approval for its Healon Duet Dual Pack ophthalmic viscosurgical device (OVD). The pack includes Healon (high viscosity) and Healon EndoCoat (dispersive) OVDs in separate sterile trays within one package to allow physicians to streamline their cataract surgery setup.

“The U.S. approval of the [dual pack] adds to Abbott’s reliable portfolio of OVD offerings that have been used for more than 25 years worldwide,” said Murthy Simhambhatla, senior vice president, Abbott Medical Optics. “Now delivered together, [the two OVDs] offer the cataract surgeon outstanding protection, control, clarity, and ease-of-use during each step of the procedure.”

To learn more about Abbott's family of Healon OVDs, visit www.abbottmedicaloptics.com.

 

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.